GRIMMT. The age of onset and the age of death in patients with dystrophia myotonia. J Genet Hum1975; 23: 301-8.
4.
WOLFA. Quinine: an effective form of treatment for myotonia. Arch Neurol Psych1936; 36: 382-3.
5.
GESCHWINDN, SIMPSONJA. Procainamide in the treatment of myotonia. Brain1955; 78: 81-91.
6.
LEYBURNP, WALTONJN. The treatment of myotonia: a controlled clinical study. Brain1959; 82: 81-91.
7.
MUNSATTL. Therapy of myotonia: a double-blind evaluation of diphenylhydantoin, procainamide and placebo. Neurology1967; 17: 359-67.
8.
FINLAYM. A comparative study of disopyramide and procainamide in the treatment of myotonia in myotonic dystrophy. J Neurol Neurosurg Psych1982; 45: 461-3.
9.
GRIGGSRC, MOSLEYRE, RIGGSJE, ENGELWK. Effects of acetazolamide on myotonia. Ann Neurol1978; 3: 531-7.
10.
BRUMBACKRA, CARLSONKM. Treatment of myotonic dystrophy with tricyclics. Muscle Nerv1983; 6: 233-4.
11.
AICHELER, PAIRH, HELLERAH. Efficacy of phenytoin, procainamide and tocainide in murine genetic myotonia. Exp Neurol1985; 87: 377-81.
12.
RUDELR, DENGLERR, RICKERK, HAASSA, EMSERW. Improved therapy of myotonia with the lidocaine derivative tocainide. J Neurol1980; 222: 275-8.
13.
STREIBEW. Successful treatment with tocainide of recessive generalized congenital myotonia. Ann Neurol1986; 19: 501-4.
14.
MIELKEU. Tocainide and myotonic dystrophy (letter). J Neurol1986; 233: 192.
15.
Tocainide hydrochloride. In: McEvoyGK ed. American Hospital Formulary Service drug information 88.Bethesda, MD: American Society of Hospital Pharmacists1988: 854-8.
16.
RODENDM, WOOSLEYRL. Drug therapy: tocainide. N Engl J Med1986; 315: 41-5.
17.
MIELKEU, HAASSA, SCHMIDTW. Antimyotonic therapy with tocainide in the myotonic dystrophy of Curschmann-Steinert. J Neurol1985; 232: 271-4.